BMC Cancer

official impact factor 3.15
Search for
Advanced search
BMC Cancer
Tools
Share this article
Open Access Research article

Polymorphisms in NF-κB Inhibitors and Risk of Epithelial Ovarian Cancer

Kristin L White1, Robert A Vierkant1, Catherine M Phelan2, Brooke L Fridley1, Stephanie Anderson1, Keith L Knutson1, Joellen M Schildkraut3, Julie M Cunningham1, Linda E Kelemen4, V Shane Pankratz1, David N Rider1, Mark Liebow1, Lynn C Hartmann1, Thomas A Sellers2 and Ellen L Goode1*

Author Affiliations

1 Mayo Clinic College of Medicine, Rochester, MN, USA

2 H. Lee Moffitt Cancer Research Institute, Tampa, FL, USA

3 Duke University, Durham, NC, USA

4 Alberta Cancer Board, Calgary, AB, USA

For all author emails, please log on.

BMC Cancer 2009, 9:170 doi:10.1186/1471-2407-9-170

Published: 6 June 2009

Additional files

Additional file 1:

SNP and Genotype Information. This table provides SNP information, quality metrics, and genotype counts of ovarian cancer cases and controls.

Format: PDF Size: 33KB Download file

This file can be viewed with: Adobe Acrobat Reader

Open Data

Additional file 2:

NFKBIA and NFKBIB Haplotypes and Ovarian Cancer Risk. This table provides estimated haplotype frequencies and results of score testing for association with ovarian cancer risk.

Format: PDF Size: 43KB Download file

This file can be viewed with: Adobe Acrobat Reader

Open Data